Helping those Affected by the Coronavirus

America’s biopharmaceutical companies are committed to developing solutions to help diagnose, treat and prevent COVID-19. The biopharmaceutical industry is providing financial support and in-kind donations to organizations and collaborating with U.S. and global health authorities to combat this global public health emergency.

More than half of PhRMA members have R&D efforts under way or are providing donations of medicines and critical medical supplies as well as providing financial donations to support patients and first responders in addressing this evolving crisis.